Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for serious diseases. They generate revenue primarily through the sale of prescription drugs, with a strong portfolio in oncology, immunology, cardiovascular, and fibrosis. The company has a rich history, including its merger with Celgene in 2019, which significantly expanded its product pipeline and research capabilities. Candidates should note Bristol Myers Squibb's commitment to scientific excellence and its strategic acquisitions to enhance its therapeutic offerings.

Recent Posts by Bristol Myers Squibb

1-20 of 1360